35992 Federal Register / Vol. 72, No. 126 / Monday, July 2, 2007 / Notices 

It implies a commitment to develop and use 

technology to help meet the most pressing human 

and societal needs, while making every reasonable effort to anticipate and mitigate adverse 

implications or unintended consequences.’’

nanotechnology, conference speakers 

and attendees are encouraged to apply 

‘‘life-cycle thinking’’ as they make 

presentations or attend conference 

sessions. Life-cycle thinking involves 

consideration of environmental and 

human health endpoints such as 

toxicity and exposure that occur over 

the material’s life cycle. Design, 

production, use, and disposal are all 

relevant to life-cycle thinking. 

The questions below are intended to 

focus presentations and discussions at 

the conference. Answers to these 

questions could help guide subsequent 

work in P2 through nanotechnology. 

1. Which nanotechnologies show the 

greatest promise for preventing 

pollution? 

Considerations: 

• This question should be viewed 

through the lens of life-cycle thinking to 

minimize the possibility of unintended 

consequences. 

• Which pollution prevention 

applications are the most likely to find 

real-world applications? 

• What barriers exist to the adoption 

of nanotechnology-enabled pollution 

prevention applications? 

2. What are the most promising areas 

of research on pollution prevention 

applications of nanotechnologies? 

Considerations: 

• Which research areas could improve 

our understanding of the full life-cycle 

of nanomaterials? 

• How can the beneficial properties of 

engineered products of nanotechnology 

such as increased surface activity, 

greater conductivity, improved strengthweight ratio, altered optical properties 

(changes in color or opacity), and flame 

retardancy be used to improve materials 

and products and reduce the production 

of pollutants at their source? 

3. What recommendations do 

conference participants have for 

promoting and encouraging pollution 

prevention in the development and 

application of nanotechnology? 

Considerations: 

• What actions could be taken, and by 

whom? 

• What mechanisms, programs, or 

associations could promote the research, 

development, and adoption of such 

applications? 

• What role can EPA programs play? 

III. Call for Posters 

Posters are an excellent forum for 

authors to present informally, yet in a 

highly visible fashion, their most recent 

work regarding pollution prevention 

through nanotechnology. A poster 

session provides an opportunity for 

authors to directly communicate with 

participants of the conference and 

engage in detailed one-on-one 

discussions. Successful posters should 

reflect the goals of the Pollution 

Prevention through Nanotechnology 

Conference. We encourage you to 

submit an entry for the poster session in 

the area of nanotechnology products, 

nanotechnology processes, or 

nanotechnology energy/resource 

efficiency. Posters with a focus on safer 

chemistries through use of 

nanotechnology are especially 

encouraged. Because of space 

constraints, a limited number of posters 

will be accepted in each area. To submit 

an entry for the poster session, please 

send a short description (less than onepage) of the poster you would like to 

display. The description should identify 

which category your poster fits within 

(products, processes, or efficient use of 

resources), how it responds to the 

concepts raised in the three questions 

listed above and how it addresses 

responsible development, and whether 

environmental benefits can be 

quantified, such as reduction of use of 

hazardous chemicals or energy or 

resource savings. Poster applications are 

due July 31, 2007. Please submit poster 

applications to the technical person 

listed under FOR FURTHER INFORMATION

CONTACT. 

IV. How Can I Request to Attend this 

Conference? 

You may register for the conference 

electronically through EPA’s website, at 

http://www.epa.gov/oppt/nano by 

September 14, 2007. Advance requests 

will assist in planning adequate seating; 

however, members of the public may 

attend without prior registration. You 

may also submit a request to attend this 

conference to the technical person listed 

under FOR FURTHER INFORMATION

CONTACT. Do not submit any information 

in your request that is considered CBI. 

Requests to attend the conference, 

identified by docket ID number EPA–

HQ–OPPT–2004–0122, must be received 

on or before September 14, 2007. 

List of Subjects Environmental 

protection, Chemicals, Pollution 

prevention, Nanotechnology, Nanoscale 

materials. 

Dated: June 25, 2007. 

Charles M. Auer, 

Director, Office of Pollution Prevention and 

Toxics. 

[FR Doc. E7–12764 Filed 6–29–07; 8:45 am] 

BILLING CODE 6560–50–S 

FEDERAL COMMUNICATIONS 

COMMISSION 

Deletion of Agenda Item From June 28, 

2007, Open Meeting in Portland, Maine 

June 28, 2007. 

The following item has been deleted 

from the Agenda scheduled for 

consideration at the June 28, 2007, Open 

Meeting in Portland, Maine and 

previously listed in the Commission’s 

Notice of June 21, 2007. 

Item 

no. Bureau Subject 

1 Media .............................................................. Title: Implementation of Section 304 of the Telecommunications Act of 1996; Commercial 

Availability of Navigation Devices; and Compatibility Between Cable Systems and Consumer Electronics Equipment. (CS Docket No. 97–80, PP Docket No. 00–67). 

Summary: The Commission will consider a Third Further Notice of Proposed Rulemaking 

concerning proposed standards to ensure bidirectional compatibility of multichannel 

video programming distribution systems and consumer electronics equipment. 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 126 / Monday, July 2, 2007 / Notices 35993 

Federal Communications Commission 

Marlene H. Dortch, 

Secretary. 

[FR Doc. 07–3234 Filed 6–28–07; 2:56 pm] 

BILLING CODE 6712–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Privacy Act of 1974; New System of 

Records 

AGENCY: Department of Health and 

Human Services (HHS), Centers for 

Disease Control and Prevention (CDC). 

ACTION: Notice of a New System of 

Records. 

SUMMARY: In accordance with the 

requirements of the Privacy Act, the 

Centers for Disease Control and 

Prevention (CDC) is proposing to 

establish a new system of records (SOR), 

09–20–0170, ‘‘National Select Agent 

Registry (NSAR)/Select Agent Transfer 

and Entity Registration Information 

System (SATERIS), HHS/CDC/ 

COTPER.’’ The purpose of the system is 

to limit access to those biological agents 

and toxins listed in 42 CFR Part 73, 9 

CFR Part 121, and 7 CFR Part 331, to 

those individuals who have a legitimate 

need to handle or use such agents or 

toxins, and who are not identified as 

restricted persons by the U.S. Attorney 

General. NSAR is a single web-based 

information management system shared 

by CDC and the U.S. Department of 

Agriculture (USDA)/Animal and Plant 

Health Inspection Service (APHIS) that 

tracks the possession, use and transfer 

of select agents and toxins that could 

pose a severe threat to public health and 

safety, to the health and safety of 

animals, and to the safety of plants or 

animal and plant products. We have 

provided background information about 

the new system in the SUPPLEMENTARY

INFORMATION section below. 

DATES: Effective Date: CDC filed a new 

SOR report with the Chair of the House 

Committee on Government Reform and 

Oversight, the Chair of the Senate 

Committee on Homeland Security & 

Governmental Affairs, and the 

Administrator, Office of Information 

and Regulatory Affairs, Office of 

Management and Budget (OMB) on June 

25, 2007. CDC invites interested parties 

to submit comments on the proposed 

routine uses. To ensure that all parties 

have adequate time in which to 

comment, the new system will be 

effective 30 days from the publication of 

this notice, or 40 days from the date it 

was submitted to OMB and the 

Congress, whichever is later, unless 

CDC receives comments that persuade 

us to defer implementation. 

ADDRESSES: Comments should be 

addressed to the CDC Privacy Act 

Officer at the address listed below. 

Comments received will be available for 

review at this location by appointment 

during regular business hours from 8 

a.m. to 4:30 p.m., Monday through 

Friday in the CDC Roybal Facility, 

Building 21, Room 8125, Atlanta, 

Georgia. 

FOR FURTHER INFORMATION CONTACT: 

Betsey S. Dunaway, Privacy Act Officer, 

Office of the Chief Science Officer, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE., 

Building 21, Room 8125, Mailstop D–74, 

Atlanta, Georgia 30333, (404) 639–4642. 

SUPPLEMENTARY INFORMATION: CDC 

proposes to establish a new system of 

records within its Coordinating Office 

for Terrorism Preparedness and 

Emergency Response (COTPER): 09–20–

0170, ‘‘National Select Agent Registry 

(NSAR)/ Select Agent Transfer and 

Entity Registration Information System 

(SATERIS), HHS/CDC/COTPER.’’ An 

important component of the nation’s 

overall terrorism deterrence policy, the 

Division of Select Agents and Toxins 

(DSAT) in the Coordinating Office for 

Terrorism Preparedness and Emergency 

Response (COTPER) within the CDC 

regulates the possession, use, and 

transfer of biological agents and toxins 

(select agents) that could pose a severe 

threat to public health and safety. A 

select agent is defined as a virus, 

bacteria, fungus or toxin that could pose 

a severe threat to public health and 

safety, to animal or plant health; or 

animal or plant products. 

I. Description of the Proposed System of 

Records 

A. Statutory and Regulatory Basis for 

SOR. The Public Health Security and 

Bioterrorism Preparedness and 

Response Act of 2002 requires entities 

to register with the U.S. Department of 

Health and Human Services (HHS) if 

they possess, use, or transfer select 

agents that could pose a severe threat to 

public health and safety. The 

Agricultural Bioterrorism Protection Act 

of 2002 requires that facilities handling 

select agents that could pose a severe 

threat to animal or plant health; or 

animal or plant products register with 

the USDA. Within HHS, the DSAT is 

responsible for registering entities and 

personnel who either possess or are 

applying for approval to possess, use or 

transfer select agents that could pose a 

severe threat to public health and safety. 

Within the USDA, APHIS has a similar 

responsibility for registering entities and 

personnel handling agents that pose a 

severe threat to animal or plant health; 

or animal or plant products. 

The Acts require safeguards and 

security measures that will adequately 

protect these agents. This includes 

controlling access and screening of 

entities and personnel through security 

risk assessments conducted by the U.S. 

Attorney General. The Acts also require 

the establishment of a national database 

of registered entities. While some 

entities register for select agents 

regulated only by HHS, others for select 

agents regulated only by USDA, there 

are a number of entities registering for 

select agents that can pose a severe 

threat to public health and safety, to 

animal health, or to animal products 

(‘‘overlap’’ select agents). Since DSAT 

and APHIS coordinate regulatory 

activities for those overlap select agents 

that would be regulated by both 

agencies, the Acts require that a single 

national database be established. This 

new Privacy Act system of records 

notice (SORN) describes the records and 

processes that enable DSAT to fulfill 

HHS’ requirements; APHIS will be 

publishing a similar SORN to address 

how USDA will fulfill theirs. 

B. Collection and Maintenance of Data 

in the System 

CDC will only collect the minimum 

amount of personal data necessary to 

achieve the purpose of this system, 

which is to limit access to the select 

agents listed in 42 CFR Part 73, 9 CFR 

Part 121, and 7 CFR Part 331, to those 

individuals who have a legitimate need 

to handle or use such agents, and who 

are not identified as a restricted person 

by the U.S. Attorney General. The data 

elements required are: name, address, 

date of birth, job title, and the name of 

the institution that would be housing 

the select agent(s). 

Entities handling select agents must 

appoint a Responsible Official within 

their organization who certifies that the 

entity meets federal requirements for 

handling select agents such as having 

security measures in place to protect the 

select agents they possess from theft, 

loss and unauthorized access, and safety 

measures to prevent the release of 

agents. DSAT’s SOR includes personal 

information on those individuals who 

have access or who have applied to have 

access to select agents, and the list of 

select agents to which they have access 

or would have access. 


jlentini on PROD1PC65 with NOTICES